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DEVELOPMENT OF AN ASYMMETRIC INTERMOLECULAR STETTER REACTION 
AND ORGANOCATALYST DESIGN 
 The intermolecular Stetter represents a powerful carbon-carbon bond forming reaction 
that involves addition of an acyl anion equivalent to an untethered Michael acceptor.  Despite the 
appeal of rendering the intermolecular reaction asymmetric, this area remains particularly 
underdeveloped. We describe a catalytic asymmetric intermolecular Stetter reaction for the 
coupling of 2-pyridinecarboxaldehydes and β-substituted vinyl triflones.  
 In pursuit of increasing the efficiency of this reaction, we developed a series of base-
activated NHC pre-catalysts that are capable of catalyzing the intramolecular Stetter reaction 
without an external base. As an indirect result of our attempts to form activated pre-catalysts, we 
discovered a catalyst hydration product, that itself generates free-carbene in solution. 
Additionally, we gathered conclusive evidence for a previously unknown SNAR type 
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The Development of an Asymmetric Intermolecular Stetter Reaction 
1.1 Introduction 
 N-heterocyclic carbenes (NHCs) have attracted considerable interest in recent years due 
to their ability to reverse the normal mode of reactivity of aldehydes, rendering them 
nucleophilic at the carbonyl carbon. This reactivity reversal is referred to as umpolung.
1
 Other 
well-known protocols to reverse the polarity of aldehydes require a protection/deprotection 
sequence with a stoichiometric reagent, most commonly a dithiane (Scheme 1.1) or a protected 
cyanohydrin. To reveal the nucleophilic acyl anion, a stong base such as n-BuLi is usually 
required.
2
 NHC pre-catalysts, on the other hand, are used in sub-stoichiometric quantities, form 
an acyl anion equivalent insitu and catalytically under mild conditions, and eliminate the need 
for protection/deprotection of the aldehyde. Most importantly, it is now possible to tune 
enantiofacial selectivity during C-C bond forming events by rational design of chiral-NHC pre-
catalysts. 
Scheme 1.1: Synthesis of α-Hydroxy Ketones Using a Dithiane Reagent  
 
 Two very important reactions that rely on the umpolung reactivity of aldehydes are the 
benzoin and Stetter reaction (Scheme 1.2). Both have undergone dramatic advancements in their 
catalytic asymmetric variants as a result of recent developments in chiral-NHC pre-catalyst 
2 
 
designs. The benzoin reaction, one of the earliest known organic reactions, is not surprisingly the 
first of these two to be applied toward asymmetric synthesis. 
Scheme 1.2: General Benzoin and Stetter Reactions 
 
1.2 The Benzoin reaction 
 The benzoin reaction was one of the earliest organic transformations found to exploit 
umpolung reactivity. Indeed, the discovery of the bezoin reaction dates back to Wohler and 
Liebig’s 1832 communication which revealed that cyanide ion can catalyze the homocoupling of 
benzaldehyde to form benzoin, an α-hydroxy ketone 1 (Scheme 1.2).
3
 In 1943, Ukai discovered 
that thiazolium salts can catalyze the same reaction,
4
 and Breslow later published his landmark 
paper in 1958 that provided an elucidated mechanism for a thiazolium-catalyzed reaction.
5
 The 
Breslow mechanism, shown in Scheme 1.3, begins with in situ formation of carbene I via 
deprotonation of the thiazolium salt by a base. Carbene I then adds to an aldehyde to form 
tetrahedral intermediate II. After proton transfer, the acyl-anion equivalent III, termed the 
Breslow intermediate, is formed. This nucleophilic alkene then adds into another equivalent of 
aldehyde to form adduct IV. Proton transfer (IV to V) and collapse of tetrahedral intermediate V 













The first asymmetric benzoin reaction was reported by Sheehan in 1966, and it featured 
chiral thiazolium pre-catalyst 2 which provided benzoin in 22% (Table 1.1).  Later improvement 
to 52% ee was acheived using precatalyst 3, although yields remained very low.
6
 Twenty years 
later, Enders utilized triazolium pre-catalyst 4, which proved a reactive scaffold that imparted 
moderate levels of enantioselectivity.
7
 Leeper was among the first to prepare a bicyclic pre-
catalyst, such as thiazolium 5, for use in the benzoin reaction.
8
 He and Rawal similarly 
hypothesized that locking a chiral substituent into a ring rather than allowing it to have free-
rotation would provide better discrimination between the two faces of the active catalyst in the 
C-C bond forming event.
8,9
 Although this early thiazolium bicyclic pre-catalyst design did not 
improve selectivities of the benzoin reaction, a related triazolium pre-catalyst 6 significantly 
4 
 
increased benzoin enantioselectivity to good levels.
10
 Further developments by Enders resulted in 
triazolium salt 7 which provided benzoin in 83% yield and 90% ee.
11
 Finally, Connon’s use of an 
electron deficient pentafluorophenyl aryl group on L-pyroglutamic acid-derived catalyst 8 
substantially increased reactivity in relation to that achieved by the related N-phenyl catalyst, 
while maintaining excellent levels of enantioselectivity.
12
  
Table 1.1: Catalysts Used In the Asymmetric Benzoin Reaction 
 
1.3 The Asymmetric Stetter Reaction 
1.3.1 Introduction 
 In 1973, Stetter greatly expanded upon the scope of acyl anion based transformations by 
successfully employing α,β-unsaturated Michael acceptors as the electrophilic component. It was 
established that aldehydes can add in a conjugately into α,β-unsaturated esters, nitriles, or 
ketones in the presence of cyanide ion or a thiazolium catalysts to form highly valuable 1,4-
5 
 
difuntionalized products (Scheme 1.2).
13
 1,4-diketones, in particular, are important synthons in 
the total synthesis of complex molecules. One high-profile example of an industrial scale Stetter 




Scheme 1.4: Pfizer’s Commercial Route to Lipitor 
 
 The proposed catalytic cycle of the Stetter reaction is based on the Breslow mechanism, 
and proceeds through common Breslow intermediate III (Scheme 1.3). This nucleophilic alkene 
adds into a Michael acceptor to afford tetrahedral intermediate VI. A second proton transfer 
occurs to give VII, which collapses to release carbene I and provide a 1,4 difunctionalized 
Stetter product. It should be noted that a recent study by our group has provided compelling 






1.3.2 The Asymmetric Intramolecular Stetter Reaction 
 Over the last 15 years, the intramolecular Stetter reaction has seen rapid development, 
particularly in its asymmetric variation. Surprisingly, the first intramolecular Stetter reaction was 
not reported until 1995 by Ciganek, which was 20 years after Stetter’s seminal report. In this 
reaction, pre-catalyst 11 mediates cyclization of aldehyde 9 to chroman-4-one 10 (Scheme 1.5).
16
 
Soon after, Enders reported the first asymmetric intramolecular Stetter reaction on the same 
substrate.  With triazolium salt 12, Enders achieved a 73% yield and 60% ee of the final 
chromanone product.
17 
Scheme 1.5: First Asymmetric Stetter Reaction            
 
 
                          
    Figure 1.1: Rovis Triazolium Scaffolds 
 
 Since 2002, our group has made significant contributions to the advancement of the 
asymmetric Stetter reaction, particularly through development of novel chiral triazolium pre-
catalysts. These can be categorized into two classes: aminoindanol-derived (14), and amino acid-
derived (13) triazolium salts (Figure 1.1).
18a,b
 In a variety of intramolecular Stetter reactions, 
high-levels of enantioselectivity have been achieved using pre-catalysts of these general motifs. 
(Scheme 1.6).
18a,c
 These transformations can also be highly diastereoselective, providing Stetter 




Scheme 1.6: Highly-Enantioselective Stetter Reactions Developed by the Rovis Group 
 
 







1.3.3 The Asymmetric Intermolecular Stetter Reaction 
 Despite the wealth of knowledge and success achieved in the asymmetric intramolecular 
Stetter reaction, transfer of this success to the asymmetric intermolecular variation has been slow 
to materialize. It wasn’t until 2008 that two concurrent reports provided major advances in this 
area, one of which was submitted by our group. In this report, we showed that glyoxamide 15 
could be coupled with alkylidenemalonates to access Stetter products in high yield and 
enantioselectivity (Scheme 1.8).
20a
 The other report was made by Enders who coupled aryl 
aldehydes with chalcone to form 1,4-diketones in good yields but modest ee’s.
21  
 
Scheme 1.8: The First Highly-Selective Asymmetric Intermolecular Stetter Reactions 
 
 
 We later expanded our method to couple glyoxamide 15 with alkylidene ketoamides, 
which allowed us to successfully attain Stetter product 16 in high yield, high ee, and good dr 
(Scheme 1.9).
20b
 That same year, we issued a separate report that featured a novel fluorinated 
9 
 
bicyclic catalyst 17, which efficiently and selectively couples a variety of aromatic aldehydes 
with β-substituted nitroalkenes in up to 95% yield and 95% ee (Scheme 1.10).
22 
Scheme 1.9: An Enantio- and Diastereoselective Stetter Utilizing Alkylidene Ketoamides 
 
Scheme 1.10: Asymmetric Stetter Reaction of Aromatic Aldehydes with Nitroalkenes 
 
1.4 Development of an Asymmetric Intermolecular Stetter Reaction 
1.4.1 Selection of an Appropriate Michael Acceptor 
 In the last several years, our group has made substantial progress in tackling difficult 
asymmetric intermolecur Stetter reactions. In general, we have had the most success with 




 and alkylidene 
ketoamides
20b
. Our goal has been to move toward less activated substrates as a way to access 
more general synthetic motifs.  
10 
 
 To evaluate the relative electrophilicity of Michael acceptors, we related thermodynamic 
acidity of α-protons of various functional groups (pKa)
24
 to the activation of the corresponding 
α,β-unsaturated Michael acceptor (Scheme 1.11). By considering that the pKa of 
trifluoro(methylsulfonyl)methane 18, for example, is 18.8, and dimethyl malonate 19 is 15.7,
26 
we assume that alkylidene malonate 20 is a more activated Michael acceptor than vinyl 
trifluoromethanesulfone (triflone) 24. We performed this analysis on a variety of Michael 
acceptors to form an approximate ranking of Michael acceptor activation. We sought to develop 
an intermolecular Stetter reaction with an acceptor that was both less-activated than substrates 
we had developed previously (21,22, and 23), but also activated enough to provide ample 
opportunity for success. With these criteria in mind, we identified vinyl triflones 24 as the ideal 
substrates for further screening. 




 2-phenyl vinyl triflone (25) was prepared
25
(Scheme 1.12) and tested under similar Stetter 
reaction conditions to those developed by DiRocco for nitroalkenes (Scheme 1.10).
22
 When 
achiral triazolium pre-catalyst 26 was used, I was delighted to find that Stetter product 27 was 
obtained in 46% yield (Scheme 1.13). With this reactivity known, we immediately shifted our 
focus toward rendering this reaction enantioselective.  
Scheme 1.12: Synthesis of Phenyl Vinyl Triflone 
 
Scheme 1.13: A New Intermolecular Stetter Reaction 
 
1.4.2 Optimization of Pre-Catalyst  
 A variety of chiral triazolium pre-catalysts that had previously been developed by our 
group were tested in the reaction (Scheme 1.14), and to our surprise, it was found that both the 
cis- (31) and trans-fluorinated triazoliums (32) lead to poor reactivity and selectivity. We had 
originally hypothesized that vinyl triflones would respond similarly to the Stetter reaction 
conditions developed for nitroalkenes, but this data indicated that the use of vinyl triflones in the 
Stetter reaction would require the development of a new set of reaction conditions. 
 Fortunately, other triazolium scaffolds that were developed within the Rovis group 
provided higher levels of reactivity and selectivity (Scheme 1.14). Based on the results for 
12 
 
triazolium 29 and 30, bulkiness at the α-keto position resulted in lower yields but increased 
selectivity. This was consistent with our understanding of these catalysts as they apply to the 
intramolecular Stetter reaction.
1
 Pre-catalyst 30 gave significantly higher levels of 
enantioselectivity than triazolium 29.Therefore, further optimization was carried out using pre-
catalyst 30.  
Scheme 1.14: Initial Catalyst Screen 
 
1.4.3 Solvent Screen  
 In addition to pre-catalyst, solvent played a vital role in both reactivity and selectivity in 
the Stetter reaction. Bulkier and less polar alcoholic solvents generally favored selectivity at the 
cost of yield (Scheme 1.15). Non-alcoholic solvents, including THF, diethyl ether, toluene, and 
dioxanes lead to either trace amounts or no Stetter product.  This is consistent with the 








Scheme 1.15: General Solvent Screen 
 
 
1.4.4 Effect of Catechol 
 Recently, DiRocco found that when 100 mol% of catechol (33) was added to the Stetter 
reaction of cinnamadehyde and nitroalkene 34, there was a significant rate enhancement with full 
retention of selectivity (Scheme 1.16).
23
 This prompted us to test the effect of catechol on the 
Stetter reaction of 2-pyridinecarboxaldehye and 2-phenyl vinyl triflone. When catechol was 
added to this reaction with t-BuOH as the solvent, yield increased from 5% to 24% without 
effecting the selectivity (Scheme 1.15). Although the exact influence of catechol on this reaction 
is not well understood, it was proposed by DiRocco and Rovis that the catechol monoanion aids 
in the rate-limiting generation of the Breslow intermediate.
15
 Subsequently, optimization of the 
Stetter reaction involving phenyl vinyl triflone included 100 mol% of catechol as an additive. 
  t-BuOH was decidedly the best solvent of those tested when combined with catechol, 
yielding product 27 in 24% yield and 80% ee. In an effort to improve the yield and selectivity of 





Scheme 1.16: Catechol Increases Yields in the Intermolecular Stetter Reaction  
Dan DiRocco, 2011 
  
1.4.5 Base Screen 
 One particular area of interest was the effect of base, especially after elimination product 
35 was identified, as well as an additional byproduct 36 which arose from a competitive Stetter 
reaction with 2 (Scheme 1.17). A brief base screen revealed that base had a notable influence on 
product distribution. An increase in the quantity of base from 20 mol% i-Pr2NEt to 100 mol% i-
Pr2NEt led to greater than 15% increase in side product 36 and greater than 5% increase in 
elimination product 35. KHMDS as base resulted in poor yields of Stetter product, but no side 
products were observed. Other bulky amine bases such as pentamethylpiperidine and DABCO 
led to even higher proportions of elimination and side product 36. Lastly, NaOAc was effective 
in this reaction with t-AmylOH, but required additional heat. At 50 
o
C, only a small amount of 





Scheme 1.17: Product Distribution Depends on Base  
 
1.4.6 Attempts to Decrease Elimination 
 Based on the identified elimination pathway, as well as an expectation that the Stetter 
product would have a particularly acidic proton at the newly formed stereocenter, efforts were 
made to reduce the acidity at this position. 2-propyl-vinyl triflone 37 was prepared
25
 and 
screened under the conditions shown in Scheme 1.18. When aminoindanol derived pre-catalyst 
30 was used, no recognizable products were observed. This was unfortunate, because pre-
catalyst 30 gave the highest selectivities when the more activated phenyl-vinyl triflone was used 
as the Michael acceptor. This study revealed that only the more reactive amino acid-derived pre-
catalysts were effective, giving the best results with pre-catalyst 39 at 28% yield and 60% ee. 
Surprisingly, when the more sterically hindered but electronically similar 2,4,6-trichlorophenyl 
pre-catalyst 40 was employed, nearly racemic product was obtained.  
16 
 
Scheme 1.18: Catalyst Screen for Stetter Reaction with 2-Propyl-Vinyl Triflone   
 
 Despite the fact that Stetter product 38 was expected to have a less acidic α-proton than 
Stetter product 27, elimination product was observed in all reactions involving triflone 37 and 
100 mol% of base. We suspected that the presence of elimination product meant that 
epimerization might be a problem, lowering the observed ee’s. To test for the epimerization of of 
Stetter product 38 under the standard reaction conditions, 100 mol% of enantioenriched 38 was 
re-subjected to the Stetter reaction of phenyl vinyl triflone and 2-pyridinecarboxaldehyde 
(Scheme 1.19). After 2 hours, the re-subjected Stetter product was re-isolated with no decrease in 
enantioenrichment. From this data, we propose that when deprotonation of Stetter product occurs 
at the acidic α-proton, elimination proceeds more rapidly than re-protonation, meaning that 






Scheme 1.19: Epimerization Experiment 
 
1.4.7 Tuning the Catalyst N-Aryl Substituent  
 Pre-catalyst was again optimized for the Stetter reaction of 2-pyridinecarboxaldehyde and 
2-phenyl vinyl triflone, this time modifying only the N-aryl group on the general pre-catalyst 41 
(Scheme 1.20). Such changes to the electronics of the N-Aryl group on this particular scaffold 
are known to have a profound effect on the efficiency on the intramolecular Stetter.
1
 Surprisingly, 
only the pentafluorophenyl pre-catalyst 30 leads to product formation. Even the similarly 
electron deficient bis(trifluoromethyl)phenyl catalysts 42 and 43 failed to yield product. 





1.4.8 Aldehyde Scope 
 One other potential handle for boosting the low reactivity of this reaction was the 
aldehyde component (Scheme 1.21). Interestingly, moving the nitrogen in the pyridine ring of 
the carboxaldehyde from the ortho position (28a) to the electronically similar para position (45a) 
in pyridinecarboxaldehyde caused total loss of reactivity. Substitution at the 6-position of 2-
pyridinecarboxaldehyde was beneficial for yields in the case of the 6-bromo-substituted aldehyde 
(46a), and both the methoxy-substituted aldehyde 47a and 2-quinolinecarboxaldehyde 48a gave 
significant increases in selectivity. A variety of other aromatic aldehydes were screened with 
very limited success (Scheme 1.22). Clearly, 2-pyridinecarboxaldehyde proves to be a privileged 
substrate in this reaction, the synthetic utility of which is consequently limited.   












Scheme 1.22: Ineffective Aldehydes 
 
1.5 Conclusion 
 In conclusion, a catalytic asymmetric intermolecular Stetter reaction has been developed 
for coupling 2-pyridinecarboxaldehydes and vinyl triflones. Our goal from the onset was to push 
the boundaries of reactivity toward the use of less-activated substrates. From that perspective, we 
have succeeded with our use of β-substituted vinyl triflones, which are among the least-activated 
Michael acceptors known to be competent in this reaction. Through our development of pre-
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The Development of Base-Activated Organocatalysts 
2.1 Introduction 
 The most convenient way to generate an N-Heterocyclic carbene is by deprotonation of  a 
corresponding azolium salt (Scheme 2.1, eq. 1) From these bench-stable pre-catalysts, the free- 
carbene is usually generated by adding a stoichiometric amount of strong base such as a metal 
hydride, potassium t-butoxide, a metal bis(trimethylsilyl)amide, or in less extreme cases, a 
tertiary amine.
1-3 
Unfortunately, a strong base can be incompatible with functional groups on the 
carbene itself, can lead to epimerization or elimination of products or reactant, and can 
participate in additional undesired side-reactions. These concerns are particularly relevant for the 
catalytic enantioselective Stetter reaction (See Chapter 1). In the Stetter reaction, it is 
advantageous to generate the catalytically active free carbene using milder conditions. 
 As illustrated in Scheme 2.1, we sought to prepare an NHC pre-catalyst with a base 
covalently attached to the counterion. By having the base electrostatically bound and in close 
proximity to an acidic triazolium moiety, we expected an increase in the concentration of 
catalytically active free-carbene. Likewise, we expected that the base would be less likely to 
participate in unwanted side reactions due to the added bulk of the electrostatically bound 
triazolium cation. We believed that this would be a worthwhile approach to solving the problem 
of low-reactivity and limited aldehyde scope in the intermolecular Stetter reaction of aldehydes 
and vinyl triflones. In addition, this system has the opportunity to increase the catalytic 




Scheme 2.1: Proposed Counterion Exchange to Form a Pre-Activated NHC Catalyst Precursor                  
 
 
2.2 Counterion Exchange in a Biphasic System 
 Our initial attempts at counterion exchange were aimed toward partitioning a starting 
counterion X
-
 (Scheme 2.1, eq. 2) into the aqueous layer of biphasic system, resulting in base-
activated triazolium salt 1 being dissolved in the organic layer. We hypothesized that this 
exchange would be particularly favorable when the byproduct MX is a highly water soluble 
inorganic compound, and the resulting triazolium salt 1 features a “greasy” anion to help 
increase its solubility in organic media. Based on Javier Read de Alaniz’s precedent for a 
quantitative yielding exchange of chloride for tetraphenylborate (Scheme 2.2), we anticipipated 
that exchange with the more common triazolium tetrafluoroborate catalyst precursors would also 
be facile.
4 
Scheme 2.2: Counterion Exchange to Form Triazolium Tetraphenylborate 2 
Javier Read de Alaniz, 2006 
 
 With these considerations in mind, we explored the use of potassium aryltrifluoroborates 
(Scheme 2.3) as counterion exchange partners, in part due to their being air-stable and crystalline 
solids, as well as their straightforward synthesis from a corresponding boronic acid.
5
 We also 
24 
 
anticipated that aryltrifluoroborates would stablilize triazolium salts similarly to the very 
commonly used tetrafluoroborate anion. 
 Potassium aryltrifluoroborate 4 was prepared in five steps from p-bromobenzaldehyde 
(Scheme 2.3).
6,7a
 This route was particularly advantageous due to the variety of possible amines 
that could be incorporated via reductive amination.
7
 With versatility at the amine functionality, it 
should be possible to fine-tune key properties of these potential counterions, such as their 
basicity. 
Scheme 2.3: Synthesis of Aryltrifluoroborate 4 Via a Reductive Amination Route 
 
 The biphasic exchange reaction of potassium aryltrifluoroborate 4 and pre-catalyst 5 
(Scheme 2.4) was attempted using a solvent system of CH2Cl2 : H2O  (1:1). After stirring for 20 
hours at ambient temperature, the organic layer was separated, the aqueous layer was extracted 
with CH2Cl2, and the combined organic phase was dried over Na2SO4. Unfortunately, only pre-
catalyst 5 was reisolated from the organic extract. We suspect that under these conditions, 4 was 
protonated by H2O to form a highly water-soluble internal ammonium salt 6. If this occurred, the 





Scheme 2.4: Initial Attempt at Biphasic Counterion Exchange Reaction  
 
 To diminish the possibility of forming 6 in a biphasic mixture, we utilized alkaline 
buffers as the aqueous phase. Both a pH=10 and a pH=12 buffer system were tested,
8
 but with 
both of these buffer systems, triazolium salt 5 was still the only species to be reisolated from the 
organic extract in considerable quantities.
9
 In both of these cases, the alkaline buffer likely 
contributed to decomposition of the of the aryltrifluoroborate. This is consistent with the Hutton 




Scheme 2.5: Hydrolysis of Phenyl Trifluoroborate Under Basic Condiions 






2.3 Counterion Exchange in Organic Media 
 Because of the difficulties we encountered with a biphasic solvent system, we pursued an 
alternate approach to tackle the problem of counterion exchange. We turned our focus toward 
devising a method that would force the precipitation of either the product triazolium salt or the 
byproduct inorganic salt. Because of our preference to abstain from using aqueous solvent, we 
chose to pursue the precipitation of an inorganic salt from organic media.   
 Our initial consideration was the use of aryltrifluoroborate 4 (Scheme 2.6), and in 
particular, how we could introduce an anion that would claim potassium from solution. Of the 
various triazolium salts available to us, the most common counterion was tetrafluoroborate, and 
less commonly chloride, bromide, and iodide. Triazolium chloride 7 was the first tested due to 




When triazolium chloride 7 was 
treated with aryltrifluoroborate 4 in acetone, we gratifyingly observed clean conversion to the 
newly formed triazolium salt 8 in 90% yield. 
Scheme 2.6: Counterion Exchange to Form Base-Activated NHC Pre-Catalyst 8 
 
2.4 Base-Activated NHC Pre-Catalysts and the Intramolecular Stetter Reaction 
 Although the 
1
H NMR analysis of 8 was identical to the overlaid spectra of the two 
starting materials, there was compelling evidence that counterion exchange did occur. For 
instance, the final product was highly-soluble in acetone, while the starting triazolium 7 was 
almost entirely insoluble. Additionally, when 20 mol% of 8 was added to aldehyde 9 in toluene 
27 
 
with no additional base present, I was delighted to find that pre-catalyst 8 was catalytically active 
in the intramolecular Stetter reaction, resulting in 30% conversion to chroman-4-one 10 (Scheme 
2.7). This represents proof of concept that base-activated NHC pre-catalysts can catalyze the 
Stetter reaction without additional base.
12
  
Scheme 2.7: Screen for Efficiency of Pre-catalyst 8 in an Intramolecular Stetter Reaction 
 
 With hopes that we could improve the level of reactivity observed by matching 
triazolium 7 with an appropriately matched base, we attempted counterion exchange with a series 
of other aryltrifluoroborates. Using the same exchange conditions from Scheme 2.6, three other 
base-activated pre-catalysts were prepared in 58 – 96% yield (Scheme 2.8). Of these, triazolium 
11b was slowly crystallized from acetone to yield single crystals suitable for X-ray 
crystallography. A crystal structure of 11b (Figure 2.1) was obtained, which provides conclusive 
evidence that the method represented in Scheme 2.8 for counterion exchange is valid.  





Figure 2.1: Crystal Structure of Base-Activated Pre-catalyst 11b 
 Pre-catalysts 11b - 13b were then tested for their efficiency in the intramolecular Stetter 
reaction. By employing the same reaction conditions as listed in Scheme 2.7, we once again 
observed modest to low conversion in the case of pre-catalyst 11b and 12b, and undetectable 
conversion in the case of 13b (Scheme 2.9).  







2.5 Toward Electron Deficient Base-Activated Pre-Catalysts  
2.5.1 Attempts at a Direct Synthesis   
 Although we were pleased to observe Stetter reactivity in the case of triazolium salts 
8,11B, and 12B, albeit modest, we were interested in increasing the efficiency of these pre-
catalysts in the Stetter reaction through simple modifications. In particular, we directed our 
attention toward replacing the N-phenyl group of the triazolium cation for an electron 
withdrawing aryl group, such as pentafluorophenyl, or 2,4,6-trichlorophenyl. Triazolium pre-
catalysts that feature electron withdrawing aryl groups are known to be particularly reactive in 
the both the intra- and intermolecular Stetter reaction.
13,14
 In fact, our group has demonstrated 
that a strong electron-withdrawing group on the triazole ring is the principal catalyst feature for 
achieving high reactivity in the Stetter reaction.
15
 
Table 2.1: Effect of Aryl Group Electronics 






 As a way to access an electron-deficient pre-catalyst with the general structure of 14 
(Scheme 2.11), we set out to prepare the previously unknown pentafluorophenyl triazolium 17. 
With this, we planned to attempt counterion exchange with aryltrifluoroborates as shown in 
30 
 
Scheme 2.8. We initiated the synthesis of 17 by first activating 2-pyrrolidinone with methyl 
Meerwein’s reagent, and subsequently added pentafluorophenyl hydrazine to form hydrazide 
15.
16
 To this was added NaHCO3 to yield a neutral hydrazone, which was acidified using HCl 
gas to afford hydrazide chloride 16 as a white precipitate (Scheme 2.11).  
 Although 15 readily undergoes cyclization to form 17 (as the tetrafluoroborate salt) when 
heated with (EtO)3CH in refluxing chlorobenzene (Scheme 2.12, Entry 1),
16 
hydrazide 16 did not 
cyclize under the same conditions (Entry 2). When 16 was heated at 80 
o
C with 
trimethylorthoformate in a sealed tube, no reaction occurred (Entry 4), but when heated in a 
sealed tube at 120 
o
C for 1 hour, complete decomposition of the starting material was observed 
(Entry 3). A variety of other conditions were explored, including adjustments to reaction time 
and temperature, solvent additives, and the addition of either catalytic or stoichiometric 
quantities of anhydrous HCl. However, all attempts at cyclization were met without success. 






Scheme 2.12: Attempts at Cyclization of Hydrazide 16  
 
 We also attempted to prepare the previously unknown N-2,4,6-trichlorophenyl pre-
catalyst 19, commencing with the preparation of hydrazide chloride 18 (Scheme 2.13). With 18 
in hand, we tested an array of cyclization techniques similar to those discussed for hydrazide 16. 
Unfortunately, we have not yet succeeded in forming pre-catalyst 19. Although we do not fully 
understand why the hydrazide chloride salts have been difficult to cyclize, we suspect that these 
salts may be more hygroscopic than the corresponding hydrazide tetrafluoroborates. If these 
hydrazides do retain added moisture, it is conceivable that cyclization may be inhibited.
16
  





2.5.2 Triazolium Chloride Salts by Counterion Exchange  
 Due to the difficulties we encounted in cyclizing hydrazide chlorides, we turned our 
attention toward developing an alternate route for obtaining an electron-deficient triazolium 
chloride salt. To avoid a problematic cyclization step, we envisioned performing a counterion 
exchange by protonation of a free-carbene with hydrogen chloride (Scheme 2.14).  
Scheme 2.14: Proposed Counterion Exchange by Protonation of a Free-Carbene 
 
  
 In a previous report by Read de Alaniz, free-carbene 23 was generated quantitatively by 
treating pre-catalyst 22 with one equivalent of KHMDS in deuterated toluene (Scheme 2.15).
4
 
Free-carbene 23 was also obtained from the tetrafluoroborate salt of pre-catalyst 22 using the 
same route (Scheme 2.15). By passing the latter carbene solution through a syringe filter, all 
traces of KBF4 were removed.
17,18
 We believed that we could utilize the insolubility of KBF4 to 
isolate a free-carbene in the form of 20, which could then be protonated to form a triazolium 
chloride salt. 
Scheme 2.15: Formation of an Isolable Free-Carbene. 






 Our ultimate goal was to access a base-activated aminoindanol-derived pre-catalyst from 
triazolium chloride 25 (Scheme 2.16). We chose this particular scaffold because our group has 
frequently observed excellent enantioselectivity in the asymmetric intra- and intermolecular 
Stetter reaction using pre-catalyst 25, but it is often a less-reactive catalyst than amino-acid 
derived scaffords.
19
 For example, pre-catalyst 24 afforded the highest ee’s for the intermolecular 
Stetter reaction of phenyl vinyl triflone with 2-pyridinecarboxaldehydes, but it failed to afford 
Stetter product when the less activated n-propyl vinyl triflone was used (see 1.4.6). We believed 
that installing an electrostatically-bound base to the triazolium pre-catalyst could improve the 
yield and substrate scope of this reaction.  
 To form triazolium 25, one equivalent of KHMDS was added to a slurry of 24 in toluene, 
and the resulting carbene solution was quickly passed through a syringe filter. Dry hydrogen 
chloride
20 
was bubbled through the filtered carbene solution under an inert atmosphere. After 
concentrating the reaction mixture and trituration using a small amount of acetone, triazolium 25 
was collected in 18% yield as a white powder.  
Scheme 2.16: Synthesis of Triazolium Chloride 25 
 
 The counterion exchange to form pre-activated catalyst precursor 27 was attempted by 
treating triazolium chloride 25 with an equimolar portion of aryltrifluoroborate 26 in acetone 
(Scheme 2.17). Unfortunately, counterion exchange did not take place.
21,22 
It is not clear why the 
exchange did not proceed as it did for triazolium 7 (Scheme 2.8), but it is possible that the more 
34 
 
electron-withdrawing triazolium 25  binds chloride more closely than triazolium 7, creating a 
higher energy-barrier for counterion exchange.  
Scheme 2.17: Failed Counterion Exchange with Electron Deficient Pre-Catalyst 25 
 
2.6 Elucidation of Pre-Catalyst Decomposition Pathways 
2.6.1 Pre-Catalyst Hydration and the Stetter Reaction 
 During investigations toward counterion exchange in organic media, we sought to 
perform a counterion exchange to generate triazolium acetate 28. Our first attempt at such an 
exchange is shown in Scheme 2.18, where one equivalent each of KOAc and triazolium 24 were 
dissolved in methanol and stirred overnight. The solution was then concentrated, re-dissoved in 
d6-acetone, and filtered to remove any remaining KOAc. The resulting 
1
H NMR was not 
consistent with triazolium acetate 28, but a new product had been formed. The mass spectra 
indicated that the major product was triazolium hydrate 29.
23 
 




 When hydrate 29 was subjected to standard intramolecular Stetter reaction conditions 
(Scheme 2.19), full conversion to chroman-4-one 10 was observed with moderate levels of 
enantioselectivity. In order to obtain the catalytically active free-carbene I, it is assumed that 
hydroxide must first be eliminated to form triazolium II with subsequent deprotonation. It is not 
clear if hydrate 29 will be synthetically useful as a pre-catalyst, but it may prove to be an 
important catalytic resting state to consider for organocatalytic reactions involving electron-poor 
azoliums.  
Scheme 2.19: Triazolium Hydrate 29 as a Pre-Catalyst 
 
2.6.2 An Unexpected SNAR Decompostion Pathway 
 In an effort to prepare larger quantities of hydrate 29, the reaction shown in Scheme 2.18 
was scaled to 0.8 grams of starting triazolium 24 (Scheme 2.20). However, the outcome was 
quite different than what was obtained on smaller scale. From the crude 
1
H NMR, it appeared 
that the reaction had only reached 20% conversion. After column chromatography, hydrate 29 
was obtained in low yield, but an interesting minor product was isolated and characterized by X-
36 
 
ray crystallography (Figure 2.2).
24




Scheme 2.20: Unexpected Catalyst Decomposition Product 30 
  
 
Figure 2.2: Crystal Structure of Catalyst Decomposition Product 30
 
 We propose the following mechanism for the formation of 30 (Scheme 2.21): Triazolium 
I is first deprotonated by KOAc to form free-carbene II. This participates in an SNAR reaction 
with the N-pentafluorophenyl group of another molecule of triazolium I to produce one 
equivalent each of triazole III and triazolium salt IV. We believe that hydroxide, generated from 
trace water and KOAc, then adds to V, which should be a highly-activated substrate for SNAR 
37 
 
hydrolysis to yield triazolium VI. Another possibility is that hydroxide performs the first SNAR 
step to yield pentafluorophenol, and then free-carbene II performs SNAR on pentafluorphenol. 
However, the aforementioned mechanism is more likely because triazolium I should be a much 
better electrophile than pentafluorophenol. 
Scheme 2.21: Proposed Mechanism for the Formation of Triazolium 30 
 
2.7 Conclusion:  
 Through the use of counterion exchange, we successfully prepared three new base-
activated NHC pre-catalysts that are each capable of self-generating catalytically active free-
carbene. One of these triazolium pre-catalysts was unambiguously assigned using X-ray 
crystallography. Additionally, in our search for new base-activated pre-catalysts, we prepared 
and isolated a triazolium hydrate, which itself is capable of forming free-carbene in solution. 
And lastly, we gathered conclusive evidence for an exciting new SNAR type decomposition 
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Appendix 1: Chapter 1 Experimental 
An Asymmetric Intermolecular Stetter Reaction 
General Methods. All reactions were carried out under an atmosphere of argon in flame or 
oven-dried glassware with magnetic stirring. Commercial reagents were purchased from Sigma-
Aldrich or Alfa Aesar and used without further purification, unless otherwise indicated. 
Aldehydes were either purchased from Aldrich or prepared via literature procedures. Vinyl 
triflones were prepared according to the general procedure as described within. Tetrahydrofuran, 
diethylether, and dichloromethane were degassed with argon and passed through two columns of 
neutral alumina. Toluene was degassed with argon and passed through one column of neutral 
alumina and one column of Q5 reactant. Methanol was purchased from Fisher Scientific and 
dried with activated 3Å molecular sieves. Column chromatography was performed on EM 
Science silica gel 60 (230-400 mesh).Thin layer chromatography was performed on SiliCycle® 
250μm 60A plates. Visualization was accomplished with UV light or either KMnO4 or p-








F NMR spectra were recorded on a Varian 300 or 400 spectrometer at 




C NMR spectra are referenced to TMS or the residual solvent 
signal. Data for 
1
H NMR are reported as follows: chemical shift in parts per million (δ, ppm), 
multiplicity (s = singlet, bs = broad singlet, d = doublet, t = triplet, q = quartet, and m = 
multiplet), coupling constants (Hz), integration. 
13
C NMR data was recorded at 75 or 100 MHz, 
and are reported as follows: chemical shift (δ, ppm). 
19
F NMR data was recorded at 376 or 282 
MHz, and are reported either as (δ, ppm), or as follows for spectra containing multiple signals: 
chemical shift (δ, ppm), multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, m = 
multiplet), coupling constant (Hz), integration. 
 Infrared spectra were obtained on a Nicolet Avatar 320 FT-IR spectrometer. High 
resolution mass spectra (HRMS) were recorded on an Agilent Technologies 6210 Time of Flight 
LC/MS. Low resolution mass spectra (LRMS) were recorded on an Agilent Technologies 6130 














General procedure for synthesis of vinyl triflones. (E)-(2-
((trifluoromethyl)sulfonyl)vinyl)benzene (25): Prepared via a slightly 
modified literature procedure.
1
 (Iodomethyl)trimethylsilane (3.24 g, 0.0151 mol) was added to 
75 mL of diethyl ether and cooled to -78 
o
C. t-BuLi in pentane (1.7 M, 18.6 mL, 0.0317 mol) 
was then added dropwise. After stirring for 1 h, freshly distilled Tf2O (2.13 g, 7.56 x 10
-3
 mol) 
was added to the solution dropwise and allowed to stir for 1.5 h. Freshly distilled benzaldehyde 
(0.802 g, 7.56 x 10
-3
 mol) was then added, and the reaction mixture stirred for 5 h. The reaction 
flask was then removed from the dry ice bath and stirred for an additional 40 min. The septum 
was then removed, and H2O (40 mL) was slowly added during stirring to eventually form a 
yellowish-brown solution. The aqueous solution was then extracted with diethyl ether (30 mL x 
3), washed with brine, and dried over Na2SO4. Rotary evaporation afforded a crude yellow solid. 
Column chromatography was performed using a gradient system of 29:1 to 15:1 (hexanes to 
ethyl acetate), and yielded 1.23 g of 25 as a white solid (69% yield). Rf (20:1 hexanes to ethyl 
acetate) = 0.28;
 1
H NMR (400 MHz; CDCl3): δ 7.90 (d, J = 15.6 Hz, 1H), 7.62-7.55 (m, 3H), 
7.51-7.48 (m, 2H), 6.83 (d, J = 15.5 Hz, 1H);
 13
C NMR (100 MHz; CDCl3): δ 153.8, 133.2, 
131.1, 129.5, 129.4, 116.6; IR (NaCl, CDCl3)  3072, 1608, 1576, 1497, 1451, 1356, 1195, 1116, 




(E)-1-((trifluoromethyl)sulfonyl)pent-1-ene (37): According to the general 
procedure, (Iodomethyl)trimethylsilane (4.85 g, 0.0227 mol), diethyl ether (75 
mL), t-BuLi in pentane (1.7 M, 32.0 mL, 0.054.5 mol), Tf2O (3.20 g, 0.0113 mol), butanal 
(0.817 g, 0.0113 mol), H2O (50 mL), and diethyl ether for extraction (35 mL x 3). Column 
chromatography, which was performed using a gradient system of 37:1 to 15:1 (hexanes to ethyl 
acetate), yielded 0.946 g of 37 as a colorless oil (41% yield). Rf (20:1 hexanes to ethyl ether) = 
0.30;
 1
H NMR (400 MHz; CDCl3): δ 7.29-7.21 (m, 1H),  6.29 (d, J = 15.3, 1H), 2.34 (dq, J = 7.2, 
1.5 Hz, 2H), 1.53 (sextet, J = 7.5 Hz, 2H),  0.92 (t, J = 7.4 Hz, 3H);
 13
C NMR (100 MHz; 
CDCl3): δ 160.4, 121.3, 34.3, 20.5, 13.3;
 19
F NMR (376 MHz; CDCl3): δ -79.2; IR (NaCl, CDCl3) 
3064, 2969, 2940, 2881, 1619, 1366, 1220, 1197, 1121; HRMS (DART) calcd for C6H9F3O2S  





t-Butanol (0.7 mL) was added via syringe to a mixture of triazolium 30 (13.2 
mg, 0.0289 mmol), 25 (41 mg, 0.174 mmol), and catechol (15.5 mg, 0.141 
mmol) under argon. 2-Pyridinecarboxaldehyde (28) (13.5 μL, 0.141 mmol) was added at once 
via syringe, and i-Pr2NEt (4.9 μL, 0.0289 mmol) was added last to form a homogenous yellow 
solution. The reaction was stirred for 2 h at 23 
o
C, at which time acetic acid (5.5 μL) was added 
to quench the reaction. The mixture was then concentrated, and purified by column 
chromatography with a gradient system of 15:1 Hexanes:EtOAc to 4:1 Hexanes:EtOAc to yield 
7.0 mg of 27 as a colorless oil (24% NMR yield, 14% isolated yield, 80% ee). Rf (1:1 CH2Cl2 to 
hexanes) = 0.26; HPLC Analysis - Chiracel IC column, 70:30 hexanes to isopropanol, 1.0 mL/ 
42 
 
min. Major enantiomer 4.82 minutes, minor enantiomer 5.24 minutes;
 1
H NMR (400 MHz; 
CDCl3): δ 8.59 (m, 1H), 7.98 (dt, J = 7.8, 1.1 Hz, 1H), 7.70 (td, J = 7.7, 1.7 Hz, 1H), 7.36-7.30 
(m, 3H), 7.24-7.20 (m, 2H), 7.18-7.14 (m, 1H), 6.11 (dd, J = 9.7, 3.8 Hz, 1H), 4.48 (ddd, J = 
14.6, 9.7, 0.8 Hz, 1H), 3.54 (ddd, J = 14.5, 3.8, 0.4 Hz, 1H);
 13
C NMR (100 MHz; CDCl3): δ 
196.0, 151.1, 149.1, 136.9, 135.2, 129.2, 128.7, 128.2, 127.7, 123.3, 120.1, 52.0, 44.0; 
19
F NMR 
(376 MHz; CDCl3): δ -78.4; IR (NaCl, CDCl3)  2925, 2854, 1702, 1583, 1494, 1438, 1367, 1205, 
1121 cm
-1
; LRMS (ES+) calcd for C15H12F3NO3S  343.05, found 344.1. 
 
1-(pyridin-2-yl)-2-(((trifluoromethyl)sulfonyl)methyl)pentan-1-one (38):  
t-Butanol (1.4 mL) was added via syringe to a mixture of triazolium 29 (25.6 
mg, 0.0565 mmol), 37 (66.6 mg, 0.330 mmol), and catechol (31.0 mg, 0.282 
mmol) under argon. 2-pyridinecarboxaldehyde (28) (27.0 μL, 0.282 mmol) 
was added at once via syringe, and i-Pr2NEt (49.1 μL, 0.282 mmol) was added last to form a 
homogenous brownish - green solution. The reaction was stirred for 1 h at 23 
o
C, at which time 
acetic acid (37 μL) was added to quench the reaction. The mixture was then concentrated, and 
purified by column chromatography with a gradient system of 15:1 to 4:1 (hexanes to ethyl 
acetate) to yield 27 mg of 38 as a colorless oil (28% isolated yield, 60 %ee). Rf (1:1 CH2Cl2 to 
hexanes) = 0.23; HPLC Analysis - Chiracel IC column, 98:2 hexanes to isopropanol, 1.0 mL/ 
min. Major enantiomer 13.78 minutes, minor enantiomer 12.44 minutes;
 1
H NMR (400 MHz; 
CDCl3): δ 8.73-8.71 (m, 1H), 8.10 (dt, J = 7.9, 1.0 Hz, 1H), 7.87 (td, J = 7.7, 1.7 Hz, 1H), 7.51 
(ddd, J = 7.6, 4.7, 1.2 Hz, 1H), 4.94-4.88 (m, 1H), 4.14 (dd, J = 14.5, 9.5 Hz, 1H), 3.38 (dd, J = 
14.4, 3.4 Hz, 1H), 1.92-1.83 (m, 1H), 1.69-1.60 (m, 1H), 1.37 (sextet, J = 7.5 Hz, 2H), 0.92 (t, J 
= 7.3, 3H);
 13
C NMR (100 MHz; CDCl3): δ 199.6, 151.5, 149.2, 137.1, 127.7, 122.9, 50.0, 38.0, 
34.3, 19.7, 13.7; 
19
F NMR (376 MHz; CDCl3): δ -78.4; IR (NaCl, CDCl3)  2966, 2936, 2878, 
1700, 1363, 1200, 1121 cm
-1
; LRMS (ES+) calcd for C12H14F3NO3S  309.06, found 310.1. 
 
1-(6-bromopyridin-2-yl)-2-phenyl-3-((trifluoromethyl)sulfonyl)propan-1-
one (46b): t-Butanol (0.7 mL) was added via syringe to a mixture of 
triazolium 30 (13.2 mg, 0.0289 mmol), 25 (41 mg, 0.174 mmol), catechol 
(15.5 mg, 0.141 mmol), and 6-bromo-2-pyridinecarbaldehyde (46a) (26.3 mg, 
0.141 mmol) under argon. i-Pr2NEt (4.9 μL, 0.0289 mmol) was added last. The reaction was 
stirred for 2.5 h at 23 
o
C, at which time acetic acid (5.5 μL) was added to quench the reaction (60% 
nmr yield, 74 %ee). A similar reaction was performed using achiral triazolium salt 26, and was 
purified by column chromatography using a solvent system of 2:1 hexanes to CH2Cl2 to yield 
46b as a colorless oil. Rf (1:1 CH2Cl2 to hexanes) = 0.55; HPLC Analysis - Chiracel IC column, 
199:1 hexanes to isopropanol, 2.0 mL/ min. Major enantiomer 6.97 minutes, minor enantiomer 
7.50 minutes; 
1
H-NMR (400 MHz; CDCl3): δ 7.94-7.92 (m, 1H), 7.59-7.52 (m, 2H), 7.34-7.31 
(m, 2H), 7.27-7.23 (m, 2H), 7.21-7.17 (m, 1H), 5.90 (dd, J = 9.8, 3.7 Hz, 1H), 4.46 (ddd, J = 
14.5, 9.8, 0.8 Hz, 1H), 3.54 (dd, J = 14.6, 3.8 Hz, 1H); 
13
C NMR (100 MHz; CDCl3): δ 194.3, 
151.5, 141.3, 139.3, 134.7, 132.5, 129.3, 128.8, 128.5, 122.1, 51.8, 44.5; 
19
F NMR (376 MHz; 
43 
 
CDCl3): δ -78.3; IR (NaCl, CDCl3)  3088, 3034, 2995, 2937, 1706, 1557, 1431, 1368, 1210, 





1-one (47b): t-Butanol (0.7 mL) was added via syringe to a mixture of 
triazolium 30 (13.2 mg, 0.0289 mmol), 25 (41 mg, 0.174 mmol), and catechol 
(15.5 mg, 0.141 mmol) under argon. 6-methoxy-2-pyridinecarbaldehyde (47a) 
(19.4 g, 17.0 μL, 0.141 mmol) was added at once via syringe, and i-Pr2NEt (4.9 μL, 0.0289 
mmol) was added last. The reaction was stirred for 2 h at 23 
o
C, at which time acetic acid (5.5 μL) 
was added to quench the reaction (15% nmr yield, 87% ee). A similar reaction was performed 
using achiral triazolium salt 26, and was purified by column chromatography using a solvent 
system of 2:1 hexanes to CH2Cl2 to yield 47b as a colorless oil. Rf (4:1 hexanes to ethyl acetate) 
= 0.24, Rf (1:1 CH2Cl2 to hexanes) = 0.37; HPLC Analysis - Chiracel IC column, 199:1 hexanes 
to isopropanol, 2.0 mL/ min. Major enantiomer 6.61 minutes, minor enantiomer 7.94 minutes; 
1
H-NMR (400 MHz; CDCl3): δ 7.72-7.64 (m, 2H), 7.37-7.26 (m, 5H), 6.91 (dd, J = 8.0, 1.1 Hz, 
1H), 5.98 (dd, J = 9.3, 4.0 Hz, 1H), 4.51 (ddd, J = 14.6, 9.3, 0.9 Hz, 1H), 3.99 (s, 3H), 3.58 (ddd, 
J = 14.6, 4.1, 0.5 Hz, 1H); 
13
C NMR (100 MHz; CDCl3): δ 195.5, 163.3, 148.5, 139.2, 135.5, 
129.3, 128.44, 128.36, 117.0, 116.5, 53.8, 52.2, 44.7; 
19
F NMR (376 MHz; CDCl3): δ -78.3; IR 
(NaCl, CDCl3)  2987, 2954, 1701, 1592, 1471, 1367, 1277, 1204, 1121, 1031, 982 cm
-1
; LRMS 
(ES+) calcd for C16H14F3NO4S  373.06, found 374.1. 
 
1,4-bis(6-methoxypyridin-2-yl)-2-phenylbutane-1,4-dione: Under 
achiral reaction conditions for the synthesis of 47b, this elimination / re-
addition product was isolated as a colorless oil. Rf (1:1 CH2Cl2 to 
hexanes) = 0.24; 
1
H-NMR (400 MHz; CDCl3): δ 7.69-7.62 (m, 3H), 
7.58 (dd, J = 7.3, 0.9 Hz, 1H), 7.46-7.43 (m, 2H), 7.31-7.27 (m, 2H), 7.23-7.19 (m, 1H), 6.92 
(dd, J = 8.2, 0.9, 1H), 6.87 (dd, J = 7.8, 1.3 Hz, 1H), 5.84 (dd, J = 10.7, 4.0 Hz, 1H), 4.30 (dd, J 
= 19.1, 10.7 Hz, 1H), 4.00 (s, 3H), 3.98, (s, 3H), 3.66 (dd, J = 19.1, 4.0 Hz); 
13
C NMR (100 
MHz; CDCl3): δ 199.7, 163.3, 163.1, 150.5, 150.0, 140.0, 138.93, 138.90, 128.8, 128.6, 126.9, 
116.2, 115.4, 115.3, 115.0, 98.6, 53.6, 53.5, 46.8, 42.8; IR (NaCl, CDCl3)  2950, 1694, 1590, 
1468, 1431, 1340, 1273, 1033, 987 cm
-1




one (48b): t-Butanol (0.7 mL) was added via syringe to a mixture of 
triazolium 30 (13.2 mg, 0.0289 mmol), 25 (41 mg, 0.174 mmol), catechol 
(15.5 mg, 0.141 mmol), and 2-quinolinecarboxaldehyde (48a) (22.2 mg, 0.141 mmol) under 
argon. i-Pr2NEt (4.9 μL, 0.0289 mmol) was added last to form a dark-red solution. The reaction 
was stirred for 2 h at 23 
o
C, at which time acetic acid (5.5 μL) was added to quench the reaction 
(15% NMR yield, 90% ee). A similar reaction was performed using achiral triazolium salt 26, 
44 
 
and was purified by column chromatography using a solvent system of 2:1 hexanes to CH2Cl2 to 
yield 48b as a colorless oil. Rf (1:1 CH2Cl2 to hexanes) = 0.42; HPLC Analysis - Chiracel IC 
column, 199:1 hexanes to isopropanol, 2.0 mL/ min. Major enantiomer 8.54 minutes, minor 
enantiomer 12.75 minutes; 
1
H NMR (400 MHz; CDCl3): δ 8.15 (d, J = 8.4 Hz, 2H), 8.04 (d, J = 
8.5 Hz, 1H), 7.75 (dd, J = 8.1, 1.3 Hz, 1H), 7.71 (ddd, J = 8.4, 6.9, 1.4 Hz, 1H), 7.56 (ddd, J = 
8.1, 6.9, 1.2 Hz, 1H), 7.42-7.39 (m, 2H), 7.24-7.20 (m, 2H), 7.16-7.11 (m, 1H), 6.36 (dd, J = 9.5, 
4.0 Hz, 1H), 4.53 (dd, J = 14.5, 9.5, 0.8 Hz, 1H), 3.62 (ddd, J = 14.5, 4.1, 0.6 Hz, 1H);
 13
C NMR 
(100 MHz; CDCl3): δ 196.1, 150.5, 147.0, 137.2, 135.5, 130.8, 130.2, 129.8, 129.2, 129.1, 128.7, 
128.2, 127.6, 119.0, 52.0, 43.9; 
19
F NMR (376 MHz; CDCl3): δ -78.3; IR (NaCl, CDCl3)  3063, 
1700, 1494, 1457, 1367, 1205, 1121, 975, 927 cm
-1
; LRMS (ES+) calcd for C19H14F3NO3S 
393.06, found 394.1. 
 
6-(naphthalen-1-yl)picolinaldehyde (49a): Prepared according to a slightly 
modified known procedure.
2
 To a suspension of 6-bromo-2 
pyridinecarboxaldehyde (125 mg, 0.672 mmol) and Pd(PPh3)4 (18.3 mg, 0.0158 
mmol) in toluene (1.2 mL), aqueous 2.0 M Na2CO3 (0.6 mL) and 1-
naphthylboronic acid (173 mg, 1.00 mmol) dissolved in methanol (0.5 mL) were 
added. The suspension was then refluxed for 16 h, at which time a 2.0 M aqueous solution of 
Na2CO3 (2.5 mL) and CH2Cl2 (6 mL) were added after the suspension had cooled to ambient 
temperature. The aqueous phase was separated, extracted with CH2Cl2, washed with brine, and 
the combined organic phase was dried using Na2SO4. Purification by column chromatography 
with a gradient system of 7.5:1 to 5:1 (hexanes to ethyl acetate) yielded 114 mg of 49a as a white 
solid (73% yield). Rf (5:1 hexanes to ethyl acetate) = 0.40; 
1
H-NMR (400 MHz; CDCl3): δ 10.20 
(d, J = 0.6 Hz, 1H), 8.07-7.99 (m, 3H), 7.98-7.94 (m, 2H), 7.82 (dd, J = 6.8, 2.0 Hz, 1H), 7.66 
(dd, J = 7.1, 1.4 Hz, 1H), 7.62-7.58 (m, 1H), 7.56-7.48 (m, 2H); 
13
C NMR (100 MHz; CDCl3): δ 
193.8, 159.9, 152.7, 137.5, 137.2, 134.0, 130.9, 129.5, 129.3, 128.5, 127.7, 126.8, 126.1, 125.3, 
125.1, 119.8; IR (NaCl, CDCl3)  3059, 2828, 1714, 1585, 1510, 1452, 1307, 1252, 1215, 989 cm
-
1
; LRMS (ES+) calcd for C17H15NO2  265.11 (MeOH sample, calcd for OMe acetal), found 266.2. 
 
1-(6-(naphthalen-1-yl)pyridin-2-yl)-2-phenyl-3-
((trifluoromethyl)sulfonyl)propan-1-one (49b): t-Butanol (0.7 mL) was 
added via syringe to a mixture of triazolium 30 (13.2 mg, 0.0289 mmol), 
25 (41 mg, 0.174 mmol), catechol (15.5 mg, 0.141 mmol), and 49a (32.9 
mg, 0.141 mmol) under argon. i-Pr2NEt (4.9 μL, 0.0289 mmol) was added 
last. The reaction was stirred for 36 h at 23 
o
C, at which time acetic acid (5.5 μL) was added to 
quench the reaction (60% nmr yield, 32% ee). A similar reaction was performed using achiral 
triazolium salt 26, and was purified by column chromatography using a solvent system of 2:1 
hexanes to CH2Cl2 to yield 49b as a colorless oil. Rf (1:1 CH2Cl2 to hexanes) = 0.36; HPLC 
Analysis - Chiracel ODH column, 90:10 hexanes to isopropanol, 1.0 mL/ min. Minor enantiomer 
8.44 minutes, major enantiomer 9.05 minutes; 
1
H-NMR (400 MHz; CDCl3): δ 8.15 (dd, J = 7.8, 
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1.1 Hz, 1H), 8.00-7.92 (m, 4H), 7.74 (dd, J = 7.8, 1.1 Hz, 1H), 7.62-7.58 (m, 1H), 7.56-7.53 (m, 
2H), 7.45 (ddd, J = 8.5, 7.0, 1.4 Hz, 1H), 7.33-7.25 (m, 5H), 6.19 (dd, J = 10.0, 3.6 Hz, 1H), 4.58 
(ddd, J = 14.6, 10.0, 0.8 Hz, 1H), 3.59 (dd, J = 14.5, 3.5 Hz, 1H); 
13
C NMR (100 MHz; CDCl3): 
δ 196.2, 158.8, 150.7, 137.6, 137.4, 135.2, 133.9, 130.9, 129.4, 129.2, 128.8, 128.4, 128.2, 127.9, 
126.7, 126.1, 125.6, 125.2, 121.6, 52.2, 44.1; 
19
F NMR (376 MHz; CDCl3): δ -78.4; IR (NaCl, 
CDCl3)  2935, 1701, 1584, 1508, 1455, 1367, 1204, 1120 cm
-1
; LRMS (ES+) calcd for 
C25H18F3NO3S  469.10, found 470.1. 
 
1-(5-bromopyridin-2-yl)-2-phenyl-3((trifluoromethyl)sulfonyl)propan-
1-one (50b): t-Butanol (0.7 mL) was added via syringe to a mixture of 
triazolium 30 (13.2 mg, 0.0289 mmol), 25 (41 mg, 0.174 mmol), catechol 
(15.5 mg, 0.141 mmol), and 5-bromo-2-pyridinecarbaldehyde (26.3 mg, 0.141 mmol) under 
argon. i-Pr2NEt (4.9 μL, 0.0289 mmol) was added last. The reaction was stirred for 2 h at 23 
o
C, 
at which time acetic acid (5.5 μL) was added to quench the reaction (60% nmr yield, 74 %ee). A 
similar reaction was performed using achiral triazolium salt 26, and was purified by column 
chromatography using a solvent system of 2:1 hexanes to CH2Cl2 to yield 50b as a colorless oil. 
Rf (1:1 CH2Cl2 to hexanes) = 0.44; HPLC Analysis - Chiracel IC column, 199:1 hexanes to 
isopropanol, 2.0 mL/ min. Major enantiomer 8.30 minutes, minor enantiomer 11.09 minutes; 
1
H-
NMR (400 MHz; CDCl3): δ 8.72 (dd, J = 2.0, 0.9 Hz, 1H), 7.97-7.91 (m, 2H), 7.38-7.35 (m, 2H), 
7.33-7.28 (m, 2H), 7.28-7.23 (m, 1H), 6.06 (dd, J = 9.9, 3.6 Hz, 1H), 4.54 (ddd, J = 14.6, 9.9, 0.9 
Hz, 1H), 3.60 (ddd, J = 14.6, 3.6, 0.5 Hz, 1H); 
13
C NMR (100 MHz; CDCl3): δ 195.1, 150.4, 
149.3, 139.8, 134.8, 129.3, 128.6, 128.4, 126.1, 124.5, 52.0, 44.1; 
19
F NMR (376 MHz; CDCl3): 






1.)  Mahadevan, A.; Fuchs, P. L. Tetrahedron Lett. 1994, 35, 6025-6028. 





















































Appendix 2: Chapter 2 Experimental 
The Development of an Asymmetric Intermolecular Stetter Reaction 
General Methods. All reactions were carried out under an atmosphere of argon in flame or 
oven-dried glassware with magnetic stirring. Commercial reagents were purchased from Sigma-
Aldrich or Alfa Aesar and used without further purification, unless otherwise indicated. 
Tetrahydrofuran, diethylether, and dichloromethane were degassed with argon and passed 
through two columns of neutral alumina. Toluene was degassed with argon and passed through 
one column of neutral alumina and one column of Q5 reactant. Methanol and acetone were 
purchased from Fisher Scientific and dried with activated 3Å molecular sieves. Column 
chromatography was performed on EM Science silica gel 60 (230-400 mesh).Thin layer 
chromatography was performed on SiliCycle® 250μm 60A plates. Visualization was 








F NMR spectra were recorded on a Varian 300 or 400 spectrometer at 




C NMR spectra are referenced to TMS or the residual solvent 
signal. Data for 
1
H NMR are reported as follows: chemical shift in parts per million (δ, ppm), 
multiplicity (s = singlet, bs = broad singlet, d = doublet, t = triplet, q = quartet, and m = 
multiplet), coupling constants (Hz), integration. 
13
C NMR data was recorded at 75 or 100 MHz, 
and are reported as follows: chemical shift (δ, ppm). 
19
F NMR data was recorded at 376 or 282 
MHz, and are reported either as (δ, ppm), or as follows for spectra containing multiple signals: 
chemical shift (δ, ppm), multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, m = 
multiplet), coupling constant (Hz), integration. 
 Melting points were measured with a MelTemp II melting point apparatus outfitted with 
an Omega type K thermocouple, and are uncorrected. Infrared spectra were obtained on a Nicolet 
Avatar 320 FT-IR spectrometer. High resolution mass spectra (HRMS) were recorded on an 
Agilent Technologies 6210 Time of Flight LC/MS. Low resolution mass spectra (LRMS) were 
recorded on an Agilent Technologies 6130 Quadrupole LC/MS. 
 
Potassium trifluoro(4-(morpholinomethyl)phenyl)borate (4): Prepared via a 
slightly modified literature procedure.
1
 Potassium trifluoro(4-
formylphenyl)borate (212 mg, 1.00 mmol), which was prepared from potassium 
trifluoro(4-formylphenyl)borate (3) via a known procedure,
2
 was added to a 
roundbottom flask charged with KHF2 (312 mg, 4.0 mmol) and a stirbar. 
Methanol (8 mL) was added by syringe, followed by morpholine (173 μL, 2.00 mmol), and the 
slurry was stirred at 23 
o
C for 4 h. Pyridine-borane complex (8M, 123 μL, 0.98 mmol) was added 
dropwise over 5 minutes, and the reaction was stirred for another 18 h. The solvent was then 
removed, and the resulting white solid was triturated with ethyl ether (2 × 20 mL). Extraction 
with 10% methanol/acetone (3 × 20 mL) was followed by concentration to nearly the point of 
saturation. Ethyl ether was added to force precipitation, which was collected by filtration to 
afford 213 mg (75% yield) of 4 as a white solid. 
1
H NMR (400 MHz, acetone-d6) δ 7.42 (d, J = 
58 
 
7.7 Hz, 2H), 7.06 (d, J = 7.5 Hz, 2H), 3.58 (t, J = 4.7 Hz, 4H), 3.38 (s, 2H), 2.35 (t, J = 4.5 Hz, 
4H); 
13
C NMR (100 MHz; acetone-d6): δ 135.2, 132.4, 128.1, 67.5, 64.5, 54.5; 
19
F NMR (376 
MHz; acetone-d6): δ -142.5; IR (NaCl, acetone-d6)  2938, 2856, 2808, 1703, 1455, 1397, 1222, 
1200, 1113, 959 cm
-1
; LRMS (ES-) calcd for C11H14BF3KNO
-
  244.11, found 244.1. 
 
General procedure for counterion exchange to form base-activated NHC pre-catalysts 
Triazolium pre-catalyst 7 (1.0 equiv.) and an aryltrifluoroborate (1.0 equiv.) were carefully 
weighed, then added to a screw-cap vial equipped with a stir bar. Under argon, dry acetone was 
added, and the vial capped. This mixture was stirred at 23 
o
C and then filtered through a 0.45 μm 
nylon syringe filter. The vial and syringe filter were rinsed with an equal amount of dry acetone. 
Evaporation of solvent afforded analytically pure product. 
 
2-Phenyl-6,7-dihydro-5H-pyrrolo[2,1-c][1,2,4]triazol-2-ium trifluoro(4-
(morpholinomethyl)phenyl)borate (8): According to the general procedure, 7 
(15.6 mg, 0.0704 mmol) and 4 (20.0 mg, 0.0706 mmol) were stirred in 0.5 mL 
of acetone for 43 h. Upon work-up, 26 mg (86% yield) of 8 was isolated as a 
yellow oil. 
1
H NMR (400 MHz, acetone-d6) δ 10.46 (s, 1H), 7.94-7.92 (m, 2H), 7.70-7.61 (m, 
3H), 7.40 (d, J = 7.4 Hz, 2H), 7.04 (d, J = 7.5 Hz, 2H), 4.61-4.57 (m, 2H), 3.59 (t, J = 4.7 Hz, 
4H), 3.38 (s, 2H), 3.33-3.28 (m, 2H), 2.95-2.87 (quintet, J = 7.5 Hz, 2H), 2.36 (t, J = 4.5 Hz, 4H); 
13
C NMR (100 MHz; acetone-d6): δ 135.5, 132.4, 131.4, 131.1, 128.1, 121.9, 67.4, 64.4, 54.5, 
48.4, 27.6, 22.4; 
19
F NMR (376 MHz; acetone-d6): δ -141.9; IR (NaCl, acetone-d6)  3133, 3032, 





(dimethylamino)phenyl) trifluoroborate (11b): According to the general 
procedure, 7 (15.5 mg, 0.0699 mmol) and 11a (15 mg, 0.0665 mmol) were 
stirred in 1.0 mL of acetone for 8 h. Upon work-up, 18 mg (72% yield) of 11b 
was isolated as a colorless oil. 
1
H NMR (300 MHz, acetone-d6) δ 10.25 (s, 1H), 7.92-7.88 (m, 
2H), 7.70-7.62 (m, 3H), 7.29 (d, J = 8.4 Hz, 2H), 6.54 (d, J = 8.2 Hz, 2H), 4.52 (t, J = 7.4 Hz, 
2H), 3.27 (t, J = 7.7 Hz, 2H), 2.91 (quintet, J = 7.6 Hz, 2H), 2.78 (s, 6H); IR (NaCl, acetone-d6)  





trifluoro(pyridin-4-yl)borate (12b): According to the general procedure, 7 
(15.8 mg, 0.0713 mmol) and 12a (13.2 mg, 0.0714 mmol) were stirred in 1.0 
mL of acetone for 8 h. Upon work-up, 23 mg (96% yield) of 12b was isolated as 
a colorless oil. Rf (95:5 CH2Cl2 to methanol) = 0.05; 
1
H NMR (400 MHz, acetone-d6) δ 10.43 (s, 
1H), 8.26 (d, J = 5.4 Hz, 2H), 7.93-7.91 (m, 2H), 7.69-7.61 (m, 3H), 7.35 (d, J = 4.5 Hz, 2H), 
4.60 (t, J = 7.4 Hz, 2H), 3.30 (t, J = 7.7 Hz, 2H), 2.91 (quintet, J = 7.5 Hz, 2H); 
13
C NMR (100 





NMR (376 MHz; acetone-d6): δ -144.3; IR (NaCl, acetone-d6)  3134, 3060, 2975, 1594, 1439, 





((phenylamino)methyl)phenyl)borate (13b): According to the general 
procedure, 7 (16.0 mg, 0.0722 mmol) and 13a (20.6 mg, 0.0712 mmol) were 
stirred in 1.0 mL of acetone for 8 h. Upon work-up, 23 mg (74% yield) of 13b 
was isolated as a colorless oil. 
1
H NMR (400 MHz, acetone-d6) δ 10.12 (s, 1H), 7.888-7.86 (m, 
2H), 7.65-7.59 (m, 3H), 7.38 (d, J = 7.8 Hz, 2H), 7.10-7.02 (m, 4H), 6.66-6.63 (m, 2H), 6.53 (tt, 
J = 7.3, 1.1 Hz, 1H), 5.16 (bs, 1H), 4.42 (t, J = 7.4 Hz, 2H), 4.18 (s, 2H), 3.14 (t, J = 7.7 Hz, 2H), 
2.74 (quintet, J = 7.5 Hz, 2H); 
13
C NMR (100 MHz; acetone-d6): δ 164.2, 150.1, 138.8, 137.2, 
136.9, 132.5, 131.3, 131.0, 129.6, 126.5, 121.8, 116.9, 113.4, 48.6, 48.2, 27.4, 22.2; 
19
F NMR 
(376 MHz; acetone-d6): δ -141.9; IR (NaCl, acetone-d6)  3408, 3022, 2926, 2850, 1699, 1602, 







H NMR (400 MHz, DMSO-d6) δ 12.31 (s, 1H), 10.45 (s, 1H), 9.08 (s, 
1H), 3.63 (t, J = 7.1 Hz, 2H), 2.91 (t, J = 8.0 Hz, 2H), 2.18 (quintet, J = 7.4 Hz, 
2H); 
19
F NMR (376 MHz; DMSO-d6): δ -155.7 (d, J = 24.8 Hz, 2F),  
-163.9 (td, J = 24.4, 3.6 Hz, 2F), -166.2 (t, J = 24.4 Hz, 1F); IR (NaCl, methanol)  3412, 3167, 
2990, 2908, 2760, 1701, 1522, 1311, 1112, 1027, 972 cm
-1
; LRMS (ES+) calcd for C10H9F5N3
+ 
 
266.07, found 266.1. 
 
(5aR,10bS)-2-(Perfluorophenyl)-4,5a,6,10b-tetrahydroindeno[2,1-
b][1,2,4]triazolo[4,3-d][1,4]oxazin-2-ium chloride (25): 
1
H NMR (400 
MHz, methanol-d4) δ 7.59 (d, J = 7.6 Hz, 1H), 7.44-7.34 (m, 3H), 6.17 (d, 
J = 4.2 Hz, 1H), 5.28 (d, J = 16.4 Hz, 1H), 5.13 (d, J = 16.4 Hz, 1H), 5.05 
(t, J = 4.3 Hz, 1H), 3.50 (dd, J = 17.1, 5.1 Hz, 1H), 3.30 (d, J = 16.8 Hz, 1H); 
13
C NMR (100 
MHz; methanol-d4): δ 152.7, 142.0, 136.2, 130.9, 128.7, 126.8, 125.0, 78.7, 63.8, 61.1, 38.2; 
19
F 
NMR (376 MHz; methanol-d4): δ -147.2 – -147.3 (m, 2F), -150.07 (tt, J = 22.2, 4.0 Hz, 1F), -
161.9 – -162.1 (m, 2F); IR (NaCl, methanol-d4)  3046, 2914, 1595, 1527, 1481, 1465, 1386, 
1075, 1001 cm
-1
; LRMS (ES+) calcd for C18H11F5N3O
+




b][1,2,4]triazolo[4,3-d][1,4]oxazin-1-ol (29): Rf (1:1 hexanes to ethyl 
acetate) = 0.20; 
1
H NMR (300 MHz, CDCl3) δ 8.26 (d, J = 12.5 Hz, 1H), 
7.30 (bs, 4H), 7.00 (bs, 0.5H), 6.31 (bs, 0.5H), 4.74-4.71(m, 1H), 4.63 (t, J 
= 4.7 Hz, 1H), 4.38-4.21 (m, 2H), 3.26 (dd, J = 16.9, 5.1 Hz, 1H), 3.12 (d, J = 16.9 Hz, 1H); 
13
C 
NMR (75 MHz; CDCl3): δ 163.8, 158.5, 139.3, 128.7, 128.4, 127.4, 125.3, 123.3, 64.3, 57.2, 
37.9, 29.3; 
19
F NMR (282 MHz; CDCl3): δ -142.8 (s, 0.5F), -143.2 (s, 0.5F), -145.8 (d, J = 19.8 
60 
 
Hz, 1F), -152.6 (t, J = 21.4 Hz, 0.5F), -153.4 (t, J = 21.4 Hz, 0.5F), -160.8 (t, J = 19.5 Hz, 1F), -




yl)phenolate (30): Rf (95:5 CH2Cl2 to methanol) = 0.08; 
1
H NMR (300 
MHz, CDCl3) δ 7.35 (d, J = 4.1 Hz, 2H), 7.21-7.13 (m, 1H), 6.71 (d, J = 
7.8 Hz, 1H), 6.01 (t, J = 3.5 Hz, 1H), 5.17-5.05 (m, 3H), 3.43 (dd, J = 
17.0, 4.5 Hz, 1H), 3.34 (d, J = 17.0 Hz, 1H), 1.86-1.62 (bs, 2H – from 
H2O); 
13
C NMR (100 MHz; CDCl3): δ 150.7, 139.7, 134.4, 130.3, 128.6, 126.0, 123.8, 98.7, 77.8, 
62.9, 62.8, 60.1, 36.9; 
19
F NMR (376 MHz; CDCl3): δ -142.3 – -142.4 (m, 1F), -144.1 (tt, J = 
21.6, 4.4 Hz, 1F), -144.2 – -144.3 (m, 1F), -144.6 – -144.7 (m, 1F), -147.3 – -147.4 (m, 1F), -
156.5 (td, J = 21.8, 6.8 Hz, 1F), -156.8 (td, J = 21.8, 6.8 Hz, 1F), -163.2 (t, J = 23.0 Hz, 1F), -
163.5 (t, J = 23.0 Hz, 1F); IR (NaCl, CDCl3)  2926, 1650, 1579, 1508, 1481, 1432, 1299, 1093, 
972 cm
-1
; HRMS (ESI) calcd for C24H10F9N3O2  543.0629, found 544.0712. 
 
References 
1.)  Molander, G. Cooper, D. J. Org. Chem. 2008, 73, 3885–3891. 

















X-Ray Crystal Structure: Chapter 2, Compound 8 
 
Table A.2.1  Crystal data and structure refinement for 8 
Identification code  rovis123 
Empirical formula  C19H22BF3N4 
Formula weight  374.22 
Temperature  120 K 
Wavelength  0.71073 Å 
Crystal system  Orthorhombic 
Space group  Pca21 
Unit cell dimensions a = 14.2408(6) Å  
 b = 6.4514(3) Å  
 c = 19.1609(8) Å  
Volume 1760.37(13) Å3 
Z 4 
Density (calculated) 1.412 Mg/m3 
Absorption coefficient 0.107 mm-1 
F(000) 784 
Crystal size 0.22 x 0.22 x 0.14 mm3 
Theta range for data collection 2.13 to 30.59°. 
Index ranges -19<=h<=20, -9<=k<=9, -27<=l<=27 
Reflections collected 36075 
Independent reflections 5356 [R(int) = 0.0506] 
Completeness to theta = 30.59° 99.8 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.9851 and 0.9767 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 5356 / 1 / 246 
62 
 
Goodness-of-fit on F2 1.095 
Final R indices [I>2sigma(I)] R1 = 0.0387, wR2 = 0.0957 
R indices (all data) R1 = 0.0526, wR2 = 0.1123 
Absolute structure parameter 0.0(5) 
Largest diff. peak and hole 0.282 and -0.327 e.Å-3 
 
 
Table A.2.2.  Atomic coordinates ( x 104) and equivalent isotropic displacement parameters 
(Å2x 103) for compound 8. U(eq) is defined as one third of the trace of the orthogonalized Uij 
tensor. 
______________________________________________________________________________ 
 x y z U(eq) 
______________________________________________________________________________ 
B(1) 2465(1) 2645(3) 1756(1) 19(1) 
C(1) 1132(1) 8294(3) 5822(1) 18(1) 
C(2) 424(1) 5412(3) 6081(1) 18(1) 
C(3) -113(1) 4234(3) 6620(1) 21(1) 
C(4) 132(1) 5469(3) 7290(1) 22(1) 
C(5) 361(1) 7701(3) 7052(1) 21(1) 
C(6) 1552(1) 7328(3) 4602(1) 17(1) 
C(7) 1736(1) 9338(3) 4394(1) 21(1) 
C(8) 2067(1) 9674(3) 3719(1) 24(1) 
C(9) 2207(1) 8021(3) 3269(1) 23(1) 
C(10) 2038(1) 6016(3) 3491(1) 22(1) 
C(11) 1707(1) 5657(3) 4165(1) 20(1) 
C(12) 1958(1) 1989(3) 1041(1) 17(1) 
C(13) 1827(1) 3355(3) 482(1) 20(1) 
C(14) 1368(1) 2793(3) -131(1) 19(1) 
C(15) 998(1) 795(3) -218(1) 18(1) 
C(16) 1135(1) -623(3) 336(1) 19(1) 
C(17) 1595(1) -9(3) 940(1) 19(1) 
C(18) 349(1) -1924(3) -975(1) 25(1) 
C(19) 476(1) 1667(3) -1401(1) 25(1) 
F(1) 1895(1) 2198(2) 2343(1) 25(1) 
F(2) 3322(1) 1525(2) 1857(1) 29(1) 
F(3) 2684(1) 4786(2) 1776(1) 26(1) 
N(1) 665(1) 7317(2) 6326(1) 18(1) 
N(2) 1162(1) 6974(2) 5286(1) 17(1) 
N(3) 715(1) 5125(2) 5439(1) 19(1) 




Table A.2.3.   Bond lengths [Å] and angles [°] for compound 8. 
_____________________________________________________ 
B(1)-F(3)  1.416(2) 
B(1)-F(1)  1.417(2) 
B(1)-F(2)  1.431(2) 
B(1)-C(12)  1.606(2) 
C(1)-N(1)  1.331(2) 
C(1)-N(2)  1.335(2) 
C(2)-N(3)  1.312(2) 
C(2)-N(1)  1.360(2) 
C(2)-C(3)  1.492(2) 
C(3)-C(4)  1.552(2) 
C(4)-C(5)  1.545(3) 
C(5)-N(1)  1.4790(19) 
C(6)-C(7)  1.382(2) 
C(6)-C(11)  1.383(2) 
C(6)-N(2)  1.4406(19) 
C(7)-C(8)  1.393(2) 
C(8)-C(9)  1.386(3) 
C(9)-C(10)  1.383(3) 
C(10)-C(11)  1.394(2) 
C(12)-C(13)  1.399(2) 
C(12)-C(17)  1.402(2) 
C(13)-C(14)  1.393(2) 
C(14)-C(15)  1.403(2) 
C(15)-N(4)  1.392(2) 
C(15)-C(16)  1.414(2) 
C(16)-C(17)  1.389(2) 
C(18)-N(4)  1.448(2) 
C(19)-N(4)  1.450(2) 






















































Table A.2.4.   Anisotropic displacement parameters (Å2x 103)for compound 8.  The anisotropic 
displacement factor exponent takes the form: - 2[ h2a*2U11 + ... + 2 h k a* b* U12 ] 
______________________________________________________________________________ 
 U11 U22 U33 U23 U13 U12 
______________________________________________________________________________ 
B(1) 21(1)  18(1) 18(1)  -2(1) 0(1)  1(1) 
C(1) 20(1)  18(1) 17(1)  -1(1) -1(1)  -4(1) 
C(2) 18(1)  16(1) 19(1)  0(1) -2(1)  -1(1) 
C(3) 22(1)  20(1) 22(1)  2(1) 2(1)  -2(1) 
C(4) 22(1)  26(1) 17(1)  2(1) 2(1)  0(1) 
C(5) 24(1)  23(1) 17(1)  -2(1) 4(1)  -2(1) 
C(6) 17(1)  20(1) 15(1)  0(1) -2(1)  -1(1) 
C(7) 25(1)  18(1) 19(1)  -1(1) 0(1)  -1(1) 
C(8) 28(1)  21(1) 21(1)  5(1) -1(1)  -4(1) 
C(9) 22(1)  31(1) 17(1)  2(1) 1(1)  -2(1) 
C(10) 23(1)  26(1) 19(1)  -5(1) -1(1)  1(1) 
C(11) 22(1)  17(1) 21(1)  -1(1) 0(1)  0(1) 
C(12) 16(1)  18(1) 18(1)  -1(1) 2(1)  0(1) 
C(13) 23(1)  15(1) 21(1)  0(1) 1(1)  -1(1) 
C(14) 21(1)  17(1) 20(1)  5(1) 1(1)  2(1) 
C(15) 17(1)  19(1) 17(1)  0(1) 1(1)  3(1) 
C(16) 21(1)  16(1) 20(1)  1(1) 0(1)  -3(1) 
C(17) 22(1)  19(1) 17(1)  3(1) 1(1)  -1(1) 
C(18) 29(1)  27(1) 21(1)  -1(1) -1(1)  -5(1) 
C(19) 27(1)  30(1) 18(1)  2(1) -4(1)  2(1) 
F(1) 30(1)  29(1) 16(1)  1(1) 2(1)  -4(1) 
F(2) 24(1)  32(1) 32(1)  -10(1) -8(1)  9(1) 
F(3) 32(1)  19(1) 26(1)  -3(1) -1(1)  -5(1) 
N(1) 19(1)  19(1) 16(1)  -1(1) -1(1)  -1(1) 
N(2) 19(1)  16(1) 16(1)  0(1) -1(1)  -2(1) 
N(3) 22(1)  15(1) 20(1)  1(1) 0(1)  -3(1) 











Table A.2.5.   Hydrogen coordinates ( x 104) and isotropic displacement parameters (Å2x 103) 
for compound 8. 
______________________________________________________________________________
 x  y  z  U(eq) 
______________________________________________________________________________ 
H(1) 1386 9622 5840 22 
H(3A) 99 2808 6651 25 
H(3B) -782 4257 6525 25 
H(4A) -396 5470 7610 26 
H(4B) 669 4856 7524 26 
H(5A) -188 8589 7071 25 
H(5B) 860 8308 7330 25 
H(7) 1641 10443 4697 25 
H(8) 2196 11016 3570 28 
H(9) 2415 8261 2816 28 
H(10) 2145 4908 3191 27 
H(11) 1592 4313 4319 24 
H(13) 2057 4700 522 23 
H(14) 1306 3758 -489 23 
H(16) 915 -1975 295 23 
H(17) 1667 -973 1297 23 
H(18A) 939 -2563 -1088 38 
H(18B) -70 -2041 -1365 38 
H(18C) 79 -2604 -577 38 
H(19A) 255 2995 -1246 37 
H(19B) 62 1137 -1753 37 








X-Ray Crystal Structure: Chapter 2, Compound 30 
 
*Note: O3 represents a molecule of H2O 
Table A.2.6.   Crystal data and structure refinement for compound 30 
 
Identification code  rovis129_0m 
Empirical formula  C24H10F9N3O3 
Formula weight  559.35 
Temperature  120 K 
Wavelength  0.71073 Å 
Crystal system  Orthorhombic 
Space group  P212121 
Unit cell dimensions a = 6.0808(3) Å  
 b = 17.0420(7) Å  
 c = 20.4648(9) Å  
Volume 2120.75(17) Å3 
Z 4 
Density (calculated) 1.752 Mg/m3 




Crystal size 0.32 x 0.24 x 0.23 mm3 
Theta range for data collection 1.55 to 30.73°. 
Index ranges -8<=h<=8, -24<=k<=24, -29<=l<=29 
Reflections collected 46309 
Independent reflections 6580 [R(int) = 0.0451] 
Completeness to theta = 30.73° 99.8 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.9621 and 0.9482 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 6580 / 0 / 352 
Goodness-of-fit on F2 1.105 
Final R indices [I>2sigma(I)] R1 = 0.0410, wR2 = 0.1044 
R indices (all data) R1 = 0.0623, wR2 = 0.1305 
Absolute structure parameter 0.3(5) 
Largest diff. peak and hole 0.382 and -0.480 e.Å-3 
 
 
Table A.2.7.   Atomic coordinates ( x 104) and equivalent isotropic displacement parameters 
(Å2x 103) for compound 30.  U(eq) is defined as one third of the trace of the orthogonalized Uij 
tensor. 
______________________________________________________________________________ 
 x y z U(eq) 
______________________________________________________________________________ 
C(1) 3075(3) 2211(1) 2429(1) 16(1) 
C(2) 2919(4) 3098(1) 3210(1) 24(1) 
C(3) 2600(5) 3402(1) 3887(1) 32(1) 
C(4) 2197(4) 1713(1) 3587(1) 18(1) 
C(5) 1595(4) 2133(1) 4235(1) 22(1) 
C(6) 2156(4) 1523(1) 4756(1) 23(1) 
C(7) 4040(3) 1076(1) 4459(1) 21(1) 
C(8) 4111(3) 1186(1) 3779(1) 18(1) 
C(9) 5681(4) 812(1) 3400(1) 22(1) 
C(10) 7256(4) 349(1) 3711(1) 26(1) 
C(11) 7206(4) 246(1) 4385(1) 27(1) 
C(12) 5577(4) 599(1) 4759(1) 25(1) 
C(13) 2999(3) 1496(1) 2052(1) 16(1) 
C(14) 1237(3) 966(1) 2116(1) 19(1) 
C(15) 1209(4) 253(1) 1809(1) 24(1) 
C(16) 2916(4) -4(1) 1382(1) 26(1) 
C(17) 4638(4) 557(1) 1306(1) 23(1) 
69 
 
C(18) 4683(3) 1261(1) 1622(1) 18(1) 
C(19) 4012(3) 3169(1) 1556(1) 19(1) 
C(20) 2553(4) 3020(1) 1051(1) 20(1) 
C(21) 3073(4) 3221(1) 415(1) 24(1) 
C(22) 5054(4) 3590(1) 286(1) 26(1) 
C(23) 6488(4) 3759(1) 784(1) 26(1) 
C(24) 5987(4) 3546(1) 1415(1) 23(1) 
F(1) -517(2) 1179(1) 2476(1) 25(1) 
F(2) -546(2) -219(1) 1897(1) 35(1) 
F(3) 6430(2) 1741(1) 1543(1) 24(1) 
F(4) 6317(2) 371(1) 899(1) 32(1) 
F(5) 622(2) 2677(1) 1174(1) 27(1) 
F(6) 1658(3) 3071(1) -65(1) 39(1) 
F(7) 5571(3) 3787(1) -326(1) 40(1) 
F(8) 8385(2) 4125(1) 655(1) 40(1) 
F(9) 7429(2) 3692(1) 1890(1) 35(1) 
N(1) 2685(3) 2307(1) 3075(1) 18(1) 
N(2) 3521(3) 2938(1) 2206(1) 19(1) 
N(3) 3460(3) 3498(1) 2692(1) 26(1) 
O(1) 3016(3) 2790(1) 4342(1) 28(1) 
O(2) 2877(3) -663(1) 1099(1) 37(1) 
O(3) 2155(5) 7857(2) 1724(2) 91(1) 
______________________________________________________________________________ 
 
Table A.2.8.   Bond lengths [Å] and angles [°] for compound 30 
_____________________________________________________ 
C(1)-N(2)  1.348(2) 
C(1)-N(1)  1.353(2) 
C(1)-C(13)  1.442(2) 
C(2)-N(3)  1.303(3) 
C(2)-N(1)  1.382(2) 
C(2)-C(3)  1.494(3) 
C(3)-O(1)  1.421(2) 
C(4)-N(1)  1.487(2) 
C(4)-C(8)  1.522(3) 
C(4)-C(5)  1.551(3) 
C(5)-O(1)  1.431(3) 
C(5)-C(6)  1.527(3) 
C(6)-C(7)  1.504(3) 
C(7)-C(12)  1.381(3) 
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C(7)-C(8)  1.405(3) 
C(8)-C(9)  1.385(3) 
C(9)-C(10)  1.395(3) 
C(10)-C(11)  1.390(3) 
C(11)-C(12)  1.389(3) 
C(13)-C(14)  1.407(3) 
C(13)-C(18)  1.410(3) 
C(14)-F(1)  1.346(2) 
C(14)-C(15)  1.368(3) 
C(15)-F(2)  1.349(3) 
C(15)-C(16)  1.425(3) 
C(16)-O(2)  1.264(2) 
C(16)-C(17)  1.427(3) 
C(17)-F(4)  1.354(2) 
C(17)-C(18)  1.363(3) 
C(18)-F(3)  1.351(2) 
C(19)-C(20)  1.385(3) 
C(19)-C(24)  1.392(3) 
C(19)-N(2)  1.420(2) 
C(20)-F(5)  1.336(2) 
C(20)-C(21)  1.382(3) 
C(21)-F(6)  1.330(3) 
C(21)-C(22)  1.384(3) 
C(22)-F(7)  1.335(2) 
C(22)-C(23)  1.372(3) 
C(23)-F(8)  1.337(3) 
C(23)-C(24)  1.376(3) 
C(24)-F(9)  1.332(2) 










































































Symmetry transformations used to generate equivalent atoms:  
 
Table A.2.9.   Anisotropic displacement parameters (Å2x 103)for compound 30. The anisotropic 
displacement factor exponent takes the form: - 2[ h2a*2U11 + ... + 2 h k a* b* U12 ] 
_____________________________________________________________________________ 
 U11 U22 U33 U23 U13 U12 
______________________________________________________________________________ 
C(1) 18(1)  16(1) 16(1)  1(1) 4(1)  2(1) 
C(2) 37(1)  15(1) 21(1)  -2(1) 4(1)  0(1) 
C(3) 61(2)  15(1) 19(1)  -2(1) 10(1)  -2(1) 
C(4) 25(1)  15(1) 14(1)  1(1) 4(1)  -2(1) 
C(5) 32(1)  18(1) 17(1)  -2(1) 6(1)  0(1) 
C(6) 33(1)  20(1) 16(1)  -1(1) 3(1)  -4(1) 
C(7) 28(1)  16(1) 18(1)  -1(1) -2(1)  -6(1) 
C(8) 22(1)  16(1) 17(1)  1(1) 1(1)  -3(1) 
C(9) 24(1)  20(1) 22(1)  4(1) 2(1)  -1(1) 
C(10) 25(1)  22(1) 32(1)  5(1) 4(1)  1(1) 
C(11) 29(1)  19(1) 32(1)  5(1) -7(1)  -3(1) 
C(12) 35(1)  18(1) 22(1)  2(1) -7(1)  -5(1) 
C(13) 22(1)  15(1) 13(1)  0(1) 0(1)  1(1) 
C(14) 21(1)  22(1) 15(1)  -2(1) 1(1)  1(1) 
C(15) 29(1)  22(1) 21(1)  -3(1) -3(1)  -7(1) 
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C(16) 36(1)  23(1) 18(1)  -5(1) -5(1)  2(1) 
C(17) 29(1)  24(1) 15(1)  -1(1) 1(1)  8(1) 
C(18) 20(1)  20(1) 16(1)  3(1) 1(1)  2(1) 
C(19) 23(1)  17(1) 17(1)  2(1) 4(1)  3(1) 
C(20) 24(1)  15(1) 22(1)  1(1) 0(1)  0(1) 
C(21) 37(1)  19(1) 18(1)  2(1) -2(1)  2(1) 
C(22) 39(1)  19(1) 19(1)  3(1) 9(1)  4(1) 
C(23) 24(1)  23(1) 30(1)  8(1) 10(1)  1(1) 
C(24) 25(1)  20(1) 23(1)  4(1) -2(1)  -1(1) 
F(1) 21(1)  33(1) 22(1)  -5(1) 5(1)  -5(1) 
F(2) 38(1)  31(1) 36(1)  -8(1) 1(1)  -17(1) 
F(3) 23(1)  22(1) 26(1)  2(1) 7(1)  0(1) 
F(4) 38(1)  31(1) 27(1)  -5(1) 11(1)  12(1) 
F(5) 24(1)  28(1) 30(1)  6(1) -2(1)  -6(1) 
F(6) 59(1)  33(1) 23(1)  4(1) -12(1)  -10(1) 
F(7) 63(1)  34(1) 22(1)  7(1) 15(1)  1(1) 
F(8) 29(1)  43(1) 47(1)  17(1) 11(1)  -6(1) 
F(9) 31(1)  42(1) 33(1)  9(1) -9(1)  -10(1) 
N(1) 27(1)  13(1) 15(1)  -2(1) 3(1)  -1(1) 
N(2) 27(1)  16(1) 16(1)  1(1) 2(1)  0(1) 
N(3) 41(1)  15(1) 20(1)  -2(1) 5(1)  0(1) 
O(1) 48(1)  18(1) 19(1)  -2(1) 4(1)  -5(1) 
O(2) 51(1)  26(1) 34(1)  -16(1) -1(1)  0(1) 
O(3) 91(2)  77(2) 105(2)  18(2) -46(2)  -34(2) 
______________________________________________________________________________ 
Table A.2.10.   Hydrogen coordinates ( x 104) and isotropic displacement parameters (Å2x 103) 
for compound 30. 
______________________________________________________________________________
 x  y  z  U(eq) 
______________________________________________________________________________ 
H(3A) 3597 3837 3967 38 
H(3B) 1106 3592 3939 38 
H(4) 956 1388 3446 22 
H(5) 40 2284 4249 27 
H(6A) 2592 1773 5161 28 
H(6B) 914 1181 4839 28 
H(9) 5685 869 2948 26 
H(10) 8349 107 3466 32 
H(11) 8271 -62 4587 32 
H(12) 5523 516 5208 30 
74 
 
 
 
 
75 
 
 
 
 
76 
 
 
 
 
 
 
 
 
 
 
 
 
 
77 
 
 
 
 
78 
 
 
 
 
79 
 
 
 
 
 
80 
 
 
 
 
81 
 
 
 
 
 
82 
 
 
 
83 
 
 
 
84 
 
 
 
